Advertisement

Fortress Biotech, Inc. FBIOP

Set alert

Price alert · FBIOP

All alert types
15.10 USD -0.49 -3.14%

At close

15.25 +0.15 +0.99%

Pre-market · Nov 2, 8:27 AM ET

Bid
15.05 × 2
Ask
15.10 × 3
15.05 Day range 15.76
6.27 52-week range 21.43
YTD
+59.11%
1 year
+120.12%
Open
15.39
Prev close
15.59
Mkt cap
62.20M
Vol
24.34K
Avg vol
12.54K
EPS
-0.863
P/E
0.00
Div yield
0.00%
More statistics
Low
15.05
High
15.76
Forward P/E
0.00
Beta
1.75
Short ratio
0.00
Inst. own
0.00%
Dividend
2.34
Ex-div date
Jun 13, 2024
50-d avg
5.83
200-d avg
10.33
1y target
0.00

MAX chart

Chart tools
Interval

Events in this range
  • Dec 14, 2017Dividend: 0.29948
  • Mar 14, 2018Dividend: 0.586
  • Jun 14, 2018Dividend: 0.586
  • Sep 13, 2018Dividend: 0.586
  • Dec 13, 2018Dividend: 0.586
  • Mar 14, 2019Dividend: 0.586
  • Jun 13, 2019Dividend: 0.586
  • Sep 12, 2019Dividend: 0.586
  • Dec 12, 2019Dividend: 0.586
  • Mar 13, 2020Dividend: 0.586
  • Jun 12, 2020Dividend: 0.586
  • Jul 17, 2020Dividend: 0.195
  • Aug 20, 2020Dividend: 0.195
  • Sep 14, 2020Dividend: 0.195
  • Oct 14, 2020Dividend: 0.195
  • Nov 12, 2020Dividend: 0.195
  • Dec 14, 2020Dividend: 0.195
  • Jan 14, 2021Dividend: 0.195
  • Feb 11, 2021Dividend: 0.195
  • Mar 12, 2021Dividend: 0.195
  • Apr 14, 2021Dividend: 0.195
  • May 13, 2021Dividend: 0.195
  • Jun 14, 2021Dividend: 0.195
  • Jul 14, 2021Dividend: 0.195
  • Aug 12, 2021Dividend: 0.195
  • Sep 14, 2021Dividend: 0.195
  • Oct 14, 2021Dividend: 0.195
  • Nov 12, 2021Dividend: 0.195
  • Dec 14, 2021Dividend: 0.195
  • Jan 13, 2022Dividend: 0.195
  • Feb 14, 2022Dividend: 0.195
  • Mar 14, 2022Dividend: 0.19531
  • Apr 13, 2022Dividend: 0.195
  • May 12, 2022Dividend: 0.195
  • Jun 14, 2022Dividend: 0.195
  • Jul 14, 2022Dividend: 0.195
  • Aug 12, 2022Dividend: 0.19531
  • Sep 14, 2022Dividend: 0.195
  • Oct 13, 2022Dividend: 0.195
  • Nov 14, 2022Dividend: 0.195
  • Dec 14, 2022Dividend: 0.195
  • Jan 12, 2023Dividend: 0.195
  • Feb 14, 2023Dividend: 0.19531
  • Mar 14, 2023Dividend: 0.19531
  • Apr 13, 2023Dividend: 0.19531
  • May 12, 2023Dividend: 0.19531
  • Jun 14, 2023Dividend: 0.19531
  • Jul 13, 2023Dividend: 0.19531
  • Aug 14, 2023Dividend: 0.19531
  • Sep 14, 2023Dividend: 0.19531
  • Oct 12, 2023Dividend: 0.19531
  • Nov 14, 2023Dividend: 0.19531
  • Dec 14, 2023Dividend: 0.19531
  • Jan 11, 2024Dividend: 0.19531
  • Feb 14, 2024Dividend: 0.19531
  • Mar 14, 2024Dividend: 0.19531
  • Apr 12, 2024Dividend: 0.19531
  • May 14, 2024Dividend: 0.19531
  • Jun 14, 2024Dividend: 0.19531
Signals (182)
NameDateAgo
SMA: BearishOct 12, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago
SMA: BearishSep 21, 20261 month ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 3, 20263 months ago
MACD: Sell SignalJul 20, 20263 months ago
SMA: BearishJul 13, 20263 months ago
RSI: OverboughtMay 18, 20265 months ago
SMA: BullishMay 11, 20265 months ago
MACD: Buy SignalMay 11, 20265 months ago
SMA: BearishMay 4, 20266 months ago
MACD: Sell SignalMay 4, 20266 months ago
SMA: BullishFeb 23, 20268 months ago
RSI: OverboughtFeb 23, 20268 months ago
SMA: BearishFeb 16, 20268 months ago
RSI: OverboughtJan 12, 20269 months ago
SMA: BullishDec 15, 202510 months ago
MACD: Buy SignalDec 15, 202510 months ago
SMA: BullishDec 1, 202511 months ago
MACD: Sell SignalOct 6, 20251 year ago
SMA: BearishSep 29, 20251 year ago
SMA: BearishSep 29, 20251 year ago
MACD: Buy SignalAug 25, 20251 year ago
SMA: BullishAug 11, 20251 year ago
MACD: Sell SignalJul 28, 20251 year ago
SMA: BearishJul 14, 20251 year ago
SMA: BullishApr 21, 20251 year ago
SMA: BullishApr 21, 20251 year ago
SMA: BearishMar 31, 20251 year ago
SMA: BearishMar 31, 20251 year ago
SMA: BullishMar 10, 20251 year ago
SMA: BullishMar 10, 20251 year ago
SMA: BearishFeb 17, 20251 year ago
SMA: BearishJan 27, 20251 year ago
SMA: BullishJan 20, 20251 year ago
SMA: BullishNov 25, 20241 year ago
RSI: OversoldNov 4, 20241 year ago
MACD: Buy SignalOct 28, 20242 years ago
RSI: OversoldAug 12, 20242 years ago
SMA: BearishJul 8, 20242 years ago
SMA: BearishJul 8, 20242 years ago
RSI: OversoldJul 8, 20242 years ago
SMA: BullishJul 1, 20242 years ago
SMA: BearishJun 24, 20242 years ago
MACD: Sell SignalJun 17, 20242 years ago
SMA: BullishJun 3, 20242 years ago
MACD: Buy SignalJun 3, 20242 years ago
SMA: BearishMay 20, 20242 years ago
MACD: Sell SignalMay 20, 20242 years ago
SMA: BullishMay 13, 20242 years ago
SMA: BearishApr 15, 20242 years ago
SMA: BullishJan 29, 20242 years ago
SMA: BearishJan 22, 20242 years ago
SMA: BullishJan 8, 20242 years ago
SMA: BearishDec 11, 20232 years ago
SMA: BullishDec 4, 20232 years ago
SMA: BullishNov 20, 20232 years ago
SMA: BearishNov 13, 20232 years ago
MACD: Buy SignalNov 13, 20232 years ago
SMA: BullishNov 6, 20232 years ago
MACD: Sell SignalAug 14, 20233 years ago
RSI: OversoldAug 14, 20233 years ago
SMA: BearishAug 7, 20233 years ago
SMA: BullishJul 31, 20233 years ago
SMA: BearishJul 24, 20233 years ago
SMA: BullishJul 17, 20233 years ago
MACD: Buy SignalJul 17, 20233 years ago
SMA: BearishJul 10, 20233 years ago
SMA: BullishJul 3, 20233 years ago
RSI: OversoldMay 29, 20233 years ago
SMA: BearishMay 15, 20233 years ago
SMA: BullishMay 8, 20233 years ago
MACD: Sell SignalMar 27, 20233 years ago
SMA: BearishMar 13, 20233 years ago
SMA: BearishMar 13, 20233 years ago
SMA: BullishFeb 27, 20233 years ago
SMA: BearishFeb 20, 20233 years ago
SMA: BullishJan 30, 20233 years ago
SMA: BullishJan 23, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BearishJan 16, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BullishJan 9, 20233 years ago
MACD: Buy SignalJan 9, 20233 years ago
MACD: Sell SignalDec 26, 20223 years ago
SMA: BearishDec 19, 20223 years ago
SMA: BearishDec 12, 20223 years ago
SMA: BullishOct 31, 20224 years ago
SMA: BullishOct 24, 20224 years ago
SMA: BearishOct 10, 20224 years ago
SMA: BullishOct 3, 20224 years ago
SMA: BearishAug 29, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BullishAug 8, 20224 years ago
MACD: Buy SignalAug 1, 20224 years ago
SMA: BullishJul 18, 20224 years ago
RSI: OversoldMay 16, 20224 years ago
SMA: BearishApr 18, 20224 years ago
SMA: BullishMar 28, 20224 years ago
RSI: OversoldFeb 28, 20224 years ago
SMA: BearishJan 24, 20224 years ago
SMA: BearishJan 24, 20224 years ago
SMA: BullishJan 3, 20224 years ago
SMA: BullishJan 3, 20224 years ago
SMA: BearishDec 27, 20214 years ago
SMA: BearishDec 27, 20214 years ago
SMA: BullishDec 20, 20214 years ago
SMA: BullishDec 20, 20214 years ago
SMA: BearishDec 13, 20214 years ago
SMA: BearishDec 13, 20214 years ago
SMA: BullishNov 29, 20214 years ago
SMA: BullishNov 29, 20214 years ago
SMA: BearishNov 22, 20214 years ago
SMA: BullishOct 4, 20215 years ago
SMA: BearishAug 9, 20215 years ago
SMA: BullishJul 26, 20215 years ago
SMA: BearishJul 19, 20215 years ago
RSI: OverboughtJun 28, 20215 years ago
SMA: BullishJun 21, 20215 years ago
SMA: BearishJun 14, 20215 years ago
MACD: Sell SignalJun 14, 20215 years ago
RSI: OverboughtApr 5, 20215 years ago
RSI: OverboughtMar 22, 20215 years ago
SMA: BullishMar 8, 20215 years ago
SMA: BearishMar 1, 20215 years ago
RSI: OverboughtFeb 1, 20215 years ago
MACD: Buy SignalNov 16, 20205 years ago
SMA: BullishNov 9, 20205 years ago
SMA: BullishNov 9, 20205 years ago
MACD: Sell SignalOct 26, 20206 years ago
SMA: BearishOct 19, 20206 years ago
SMA: BearishOct 12, 20206 years ago
SMA: BullishSep 28, 20206 years ago
SMA: BearishSep 21, 20206 years ago
SMA: BullishAug 10, 20206 years ago
SMA: BullishAug 3, 20206 years ago
SMA: BearishJun 22, 20206 years ago
MACD: Buy SignalMay 4, 20206 years ago
SMA: BullishApr 20, 20206 years ago
RSI: OversoldMar 9, 20206 years ago
MACD: Sell SignalFeb 17, 20206 years ago
SMA: BearishFeb 10, 20206 years ago
SMA: BearishFeb 10, 20206 years ago
SMA: BullishFeb 3, 20206 years ago
SMA: BullishFeb 3, 20206 years ago
MACD: Buy SignalFeb 3, 20206 years ago
SMA: BearishJan 27, 20206 years ago
SMA: BearishJan 27, 20206 years ago
MACD: Sell SignalJan 27, 20206 years ago
SMA: BullishJan 13, 20206 years ago
MACD: Buy SignalJan 13, 20206 years ago
SMA: BullishDec 30, 20196 years ago
SMA: BearishNov 18, 20196 years ago
SMA: BearishNov 18, 20196 years ago
SMA: BullishOct 14, 20197 years ago
SMA: BullishSep 30, 20197 years ago
SMA: BearishSep 9, 20197 years ago
SMA: BearishAug 19, 20197 years ago
MACD: Sell SignalAug 19, 20197 years ago
SMA: BullishApr 15, 20197 years ago
SMA: BearishApr 1, 20197 years ago
SMA: BullishJan 28, 20197 years ago
MACD: Buy SignalJan 7, 20197 years ago
SMA: BullishDec 31, 20187 years ago
MACD: Sell SignalDec 17, 20187 years ago
SMA: BearishDec 10, 20187 years ago
MACD: Buy SignalNov 26, 20187 years ago
SMA: BullishNov 19, 20187 years ago
RSI: OversoldOct 22, 20188 years ago
SMA: BearishOct 8, 20188 years ago
SMA: BullishOct 1, 20188 years ago
SMA: BearishSep 17, 20188 years ago
SMA: BullishSep 10, 20188 years ago
RSI: OversoldJul 30, 20188 years ago
SMA: BearishMay 21, 20188 years ago
SMA: BullishMay 14, 20188 years ago
SMA: BearishApr 2, 20188 years ago
SMA: BullishMar 26, 20188 years ago
SMA: BearishMar 19, 20188 years ago
SMA: BullishMar 12, 20188 years ago
SMA: BearishMar 5, 20188 years ago
SMA: BullishFeb 19, 20188 years ago

Key statistics

Market cap
35.16M
Enterprise value
96.10M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.43
Price / book
4.39
EPS (TTM)
-0.863
Beta
1.75
Dividend yield
45.96%
Payout ratio
0.00%
Profit margin
-49.25%
Revenue (TTM)
82.62M
Revenue growth
-14.30%
Free cash flow
-59.20M
Total cash
76.20M
Total debt
88.42M
Return on equity
0.00%
Shares outstanding
56.68M
Short % of float
0.00%
50-day average
5.83
200-day average
10.33

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

About Fortress Biotech, Inc.

Fortress Biotech, Inc., a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; Cosibelimab for metastatic cancers; Olafertinib for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and DFD-29 for the treatment of rosacea. The company's early stage product candidates include Dotinurad for gout; MB-106 for B-cell non-hodgkin lymphoma; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma; AJ201, an androgen receptor degradation enhancer; BAER-101, a positive allosteric modulator; MB-117 for newly diagnosed x-linked severe combined immunodeficiency; and MB217 for previously transplanted; and MB-110 for RAG1 severe combined immunodeficiency. Its preclinical product candidates comprise Mayo Clinic In Vivo CAR T Platform Technology; AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on FBIOP — it syncs with the Stock Master app.

Insider holders

FBIOP insider holders
InsiderRelationLatest transactionDateShares held
JIN DAVIDChief Financial OfficerPurchaseJul 9, 2024500
ROSENWALD LINDSAY AChief Executive OfficerPurchaseJul 10, 2024127,500

Institution ownership

FBIOP institution ownership
Holder% heldSharesValueReported
Shikiar Asset Management, Inc.0.44%15,00098.25KJun 29, 2023
Advertisement